Lanean...
Emerging treatments in lung cancer – targeting the RLIP76 molecular transporter
Multidrug resistance in lung cancer cells is a significant obstacle in the treatment of lung cancer. Resistance to chemotherapeutic agents is often the result of efflux of the drugs from cancer cells, mediated by adenosine triphosphate (ATP)-dependent drug transport across the plasma membrane. Thus,...
Gorde:
| Argitaratua izan da: | Lung Cancer (Auckl) |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Dove Medical Press
2013
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4240306/ https://ncbi.nlm.nih.gov/pubmed/25419163 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/LCTT.S53672 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|